Prestige Consumer Healthcare Inc. $PBH Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC increased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 298.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 21,235 shares of the company’s stock after buying an additional 15,910 shares during the quarter. SG Americas Securities LLC’s holdings in Prestige Consumer Healthcare were worth $1,696,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. UMB Bank n.a. boosted its holdings in Prestige Consumer Healthcare by 81.8% in the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after acquiring an additional 144 shares during the period. Caitong International Asset Management Co. Ltd raised its stake in shares of Prestige Consumer Healthcare by 312.5% during the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock valued at $26,000 after purchasing an additional 250 shares during the period. Maseco LLP acquired a new position in shares of Prestige Consumer Healthcare during the second quarter worth $27,000. First Horizon Advisors Inc. grew its holdings in Prestige Consumer Healthcare by 294.1% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the company’s stock valued at $48,000 after purchasing an additional 447 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in Prestige Consumer Healthcare by 92.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 559 shares of the company’s stock worth $48,000 after buying an additional 269 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $59.08 on Friday. The company has a market cap of $2.84 billion, a PE ratio of 13.87, a P/E/G ratio of 1.93 and a beta of 0.41. Prestige Consumer Healthcare Inc. has a fifty-two week low of $58.03 and a fifty-two week high of $90.04. The firm has a 50-day simple moving average of $61.81 and a 200 day simple moving average of $71.89. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, November 6th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.10. The company had revenue of $274.11 million during the quarter, compared to the consensus estimate of $257.14 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.09 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Sidoti upgraded Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 target price for the company in a research note on Wednesday, September 24th. Weiss Ratings reissued a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, October 8th. Wall Street Zen cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Zacks Research upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Finally, Canaccord Genuity Group dropped their target price on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Four research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $85.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.